Amendment 0002
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D221R0102
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents3
This procurement notice, issued by DLA Troop Support, pertains to Amendment 0002 of solicitation SPE2D221R0102. The primary purpose of this amendment is to correct the offer due date and local time as previously stated in Amendment 0001. The revised deadline for submission of offers is now set for September 14, 2021, at 3:00 PM EDT.
The solicitation falls under NAICS Code 325412, which covers Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on pharmaceutical products. This suggests that the procurement activity is centered on the acquisition of pharmaceutical preparations, likely for use in supporting military or federal healthcare operations.
DLA Troop Support, a federal office, serves as the contracting entity for this opportunity. Contractors interested in this solicitation should note that all communications and submissions are to be directed to the designated points of contact: Denise Taubman ([email protected], 215-737-6877) and Phyllis Daraio ([email protected], 215-737-7941). These contacts can provide further clarification regarding the solicitation and amendment details.
The procurement is being conducted as a Combined Synopsis/Solicitation, streamlining the process by combining the synopsis and solicitation into a single step. While the amendment notice does not specify set-aside requirements or special considerations, contractors should review the full solicitation and its attachments for any additional instructions or eligibility criteria.
The intended outcome of this procurement is to secure reliable sources for pharmaceutical preparations, ensuring that DLA Troop Support can fulfill its mission of providing critical medical supplies to its stakeholders. Contractors with capabilities in pharmaceutical manufacturing and supply are encouraged to evaluate the solicitation documents, accessible via the provided SAM.gov link, to determine alignment with their offerings and compliance with federal procurement standards.
This opportunity remains active as of the posting date, and interested parties should adhere strictly to the revised submission deadline. All relevant attachments and further details are available through the official SAM.gov opportunity page.